The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지
DOI QR코드

DOI QR Code

Proposal of Evidence-based East-West Integrative Medicine Manual for Vascular Dementia

혈관성 치매에 대한 근거기반 의한 협진 매뉴얼 제안

  • Received : 2019.02.11
  • Accepted : 2019.03.13
  • Published : 2019.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This study was made by Chung Yeon Korean Medicine Hospital in order to perform appropriate East-West integrative medicine. The purpose of this manual is to support decision-making and communication in the implementation of the East-West cooperative treatment of vascular dementia. Methods: In order to carry out this study, it is based on search terms such as 'vascular dementia', 'acupuncture', 'herbal medicine', 'integrative medicine', 'chinese traditional medicine', and 'cognitive function' in databases such as MEDLINE, EMBASE, OASIS and CNKI We collected references. The drafting proceeded with the collaboration of two specialists of the Korean medicine, and the disagreement on the basis of the quotation was determined through a two person agreement. After, The draft was reviewed by a western medical doctor(rehabilitation specialist). Then, The opinions of the entire medical staff of the committee were reflected in the draft and finalized the agreement. Results: Through this study, manuals for diagnosis, treatment, and other considerations in the process of applying East-West integrative medicine to vascular dementia were derived. Conclusions: This study has significance in that it provides manual information about the decision structure, treatment contents, role distribution, etc. of East-West integrative medicine within the medical institution that conducts the vascular dementia consultation. In order for this study to function as a generalized medical guideline, it is necessary to improve the research methodology and carry out professional consensus procedures.

Keywords

References

  1. O'Brien JT, Thomas A. Vascular dementia. Lancet. 2015;386(10004):1698-706. https://doi.org/10.1016/S0140-6736(15)00463-8
  2. Rodriguez Garcia PL, Rodriguez Garcia D. Diagnosis of vascular cognitive impairment and its main categories. Neurologia. 2015;30(4):223-39. https://doi.org/10.1016/j.nrl.2011.12.014
  3. Kokmen E, Whisnant JP, O'Fallon WM, Chu CP, Beard CM. Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology. 1996;46:154-159. https://doi.org/10.1212/WNL.46.1.154
  4. Al-Qazzaz NK, Ali SH, Ahmad SA, Islam S, Mohamad K. Cognitive impairment and memory dysfunction after a stroke diagnosis: a post-stroke memory assessment. Neuropsychiatr Dis Treat. 2014;10:1677-91.
  5. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009 Nov;8(11):1006-18. https://doi.org/10.1016/S1474-4422(09)70236-4
  6. Allan LM, Rowan EN, Firbank MJ, Thomas AJ, Parry SW, Polvikoski TM, et al. Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors. Brain. 2011;134(Pt 12):3716-27. https://doi.org/10.1093/brain/awr273
  7. Xu QQ, Shan CS, Wang Y, Shi YH, Zhang QH, Zheng GQ. Chinese Herbal Medicine for Vascular Dementia: A Systematic Review and Meta-Analysis of High-Quality Randomized Controlled Trials. J Alzheimers Dis. 2018;62(1):429-456. https://doi.org/10.3233/JAD-170856
  8. Wang S, Yang H, Zhang J, Zhang B, Liu T, Gan L, et al. Efficacy and safety assessment of acupuncture and nimodipine to treat mild cognitive impairment after cerebral infarction: a randomized controlled trial. BMC Complement Altern Med. 2016;16(1):361. https://doi.org/10.1186/s12906-016-1337-0
  9. Cao HX, Wang YY. Clinical practice guideline in traditional Chinese medicine for ischemic stroke. In: Evidence-based guideline of clinical practice in Chinese medicine. 1st ed. Beijing: China Press of Traditional Chinese Medicine. 2011.
  10. Lee GE, Jeon WK, Heo EJ, Yang HD, Kang HW. The study on the korean traditional medical treatment and system of collaborative practice between korean traditional medicin and western medicine for dementia : based on analysis of questionnaire survey in professional group. J of Oriental Neuropsychiatry. 2012:23(4):49-68. https://doi.org/10.7231/jon.2012.23.4.049
  11. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43(2):250-60. https://doi.org/10.1212/WNL.43.2.250
  12. van Straaten EC, Scheltens P, Knol DL, van Buchem MA, van Dijk EJ, Hofman PA, et al. Operational definitions for the NINDS-AIREN criteria for vascular dementia: an interobserver study. Stroke. 2003;34(8):1907-12. https://doi.org/10.1161/01.STR.0000083050.44441.10
  13. de Bruijn RF, Ikram MA. Cardiovascular risk factors and future risk of Alzheimer's disease. BMC Med. 2014 Nov 11;12:130. https://doi.org/10.1186/s12916-014-0130-5
  14. Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF 3rd. Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2013;202(5):329-35. https://doi.org/10.1192/bjp.bp.112.118307
  15. O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, et al. Vascular cognitive impairment. Lancet Neurol. 2003;2(2):89-98. https://doi.org/10.1016/S1474-4422(03)00305-3
  16. Stebbins GT, Nyenhuis DL, Wang C, Cox JL, Freels S, Bangen K, et al. Gray matter atrophy in patients with ischemic stroke with cognitive impairment. Stroke. 2008;39(3):785-93. https://doi.org/10.1161/STROKEAHA.107.507392
  17. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA. 2002;288 (12):1475-83. https://doi.org/10.1001/jama.288.12.1475
  18. Gupta M, Dasgupta A, Khwaja GA, Chowdhury D, Patidar Y, Batra A. Behavioural and psychological symptoms in poststroke vascular cognitive impairment. Behav Neurol. 2014;2014:430128.
  19. Tsoi KK, Chan JY, Hirai HW, Wong SY, Kwok TC. Cognitive Tests to Detect Dementia: A Systematic Review and Meta-analysis. JAMA Intern Med. 2015;175(9):1450-8. https://doi.org/10.1001/jamainternmed.2015.2152
  20. Reisberg B. Global measures: utility in defining and measuring treatment response in dementia. Int Psychogeriatr. 2007;19(3):421-56. https://doi.org/10.1017/S1041610207005261
  21. Choi SH, Na DL, Lee BH, Hahm D, Jeong JH, Yoon SJ, et al.; Dementia Research Group. Estimating the va-lidity of the Korean version of Expanded Clinical Dementia Rating (CDR) scale. J Korean Neurol Assoc. 2001;19:585-91.
  22. Choi SH, Na DL, Lee BH, Halm D, Jeong JH, Jeong Y, et al.; Dementia Research Group. Ihe validity of the Korean version of Global Deterioration Scale. J Korean Neurol Assoc. 2002;20:612-7.
  23. Shin MH, Lee YM, Park JM, Kang CJ, Lee BD, Moon E, et al. A combination of the korean version of the mini-mental state examination and korean dementia screening questionnaire is a good screening tool for dementia in the elderly. Psychiatry Investig. 2011;8(4):348-53. https://doi.org/10.4306/pi.2011.8.4.348
  24. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-9. https://doi.org/10.1111/j.1532-5415.2005.53221.x
  25. Kang SJ, Seong SH, Lee BH, Kwon JC, Na DL, Han SH.; Korean dementia research group. The reliability and validity of the korean instrumental activities of daily living (K-IADL). J Korean Neurol Assoc. 2002;20(1):8-14.
  26. Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, et al. Cerebral blood flow in dementia. Arch Neurol. 1975;32(9):632-7. https://doi.org/10.1001/archneur.1975.00490510088009
  27. Korean Dementia Association. Dementia A clinical Approach. 2nd ed. Academiya. 2011:424.
  28. Price CC, Jefferson AL, Merino JG, Heilman KM, Libon DJ. Subcortical vascular dementia: integrating neuropsychological and neuroradiologic data. Neurology. 2005;65(3):376-82. https://doi.org/10.1212/01.WNL.0000168877.06011.15
  29. Fein G, Di Sclafani V, Tanabe J, Cardenas V, Weiner MW, Jagust WJ, et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology. 2000;55(11):1626-35. https://doi.org/10.1212/WNL.55.11.1626
  30. Lee GE, Moon KS, Kim NK, Chung SY, Jung IC, Kang HW. Preliminary study to develop the Korean medical pathologic aging scale and korean medical pattern identification for dementia. J Korean Med. 2017:38(3):111-23. https://doi.org/10.13048/jkm.17030
  31. Korean society of oriental neuropsychiatry. Korean Medicine Clinical Practice Guideline for Dementia. Seoul:Guideline center for Korean Medicine. 2017.
  32. Bahar-Fuchs A, Clare L, Woods B. Cognitive training and cognitive rehabilitation for persons with mild to moderate dementia of the Alzheimer's or vascular type: a review. Alzheimers Res Ther. 2013;5(4):35. https://doi.org/10.1186/alzrt189
  33. Spector A, Charlesworth G, King M, Lattimer M, Sadek S, Marston L, et al. Cognitive-behavioural therapy for anxiety in dementia: pilot randomised controlled trial. Br J Psychiatry. 2015;206(6):509-16. https://doi.org/10.1192/bjp.bp.113.140087
  34. Kwon KJ, Kim MK, Lee EJ, Kim JN, Choi BR, Kim SY, et al. Effects of donepezil, an acetylcholinesterase inhibitor, on neurogenesis in a rat model of vascular dementia. J Neurol Sci. 2014;347(1-2):66-77. https://doi.org/10.1016/j.jns.2014.09.021
  35. Scapicchio PL. Revisiting choline alphoscerate profile: a new, perspective, role in dementia?. Int J Neurosci. 2013;123(7):444-9. https://doi.org/10.3109/00207454.2013.765870
  36. Alvarez-Sabin J, Roman GC. Citicoline in vascular cognitive impairment and vascular dementia after stroke. Stroke. 2011;42(1 Suppl):S40-3. https://doi.org/10.1161/STROKEAHA.110.606509
  37. Ye Y, Zhu W, Wang XR, Yang JW, Xiao LY, Liu Y, et al. Mechanisms of acupuncture on vascular dementia-A review of animal studies. Neurochem Int. 2017 Jul;107:204-210. https://doi.org/10.1016/j.neuint.2016.12.001
  38. Ye Y, Li H, Yang JW, Wang XR, Shi GX, Yan CQ, et al. Acupuncture Attenuated Vascular Dementia-Induced Hippocampal Long-Term Potentiation Impairments via Activation of D1/D5 Receptors. Stroke. 2017;48(4):1044-1051. https://doi.org/10.1161/STROKEAHA.116.014696
  39. Li SK, Ding DM, Zhang ZL, Ma L, Huang HY, Wu XH. Effects of scalp acupuncture combined with auricular point sticking on cognitive behavior ability in patients with vascular dementia. Zhongguo Zhen Jiu. 2014;34(5):417-20.
  40. Lee GE, Yang HD, Heo EJ, Jeon WK, Lyu YS, Kang HW. The current state of clinical studies on scalp acupuncture-treatment for dementia by search for China literature published from 2001 to 2011 in CAJ. J of Oriental Neuropsychiatry. 2012:23(2):13-32. https://doi.org/10.7231/JON.2012.23.2.013
  41. Liu Q, Wang XJ, Zhang ZC, Xue R, Li P, Li B. Neuroprotection against vascular dementia after acupuncture combined with donepezil hydrochloride: P300 event related potential. Neural Regen Res. 2016;11(3):460-4. https://doi.org/10.4103/1673-5374.179059
  42. Shi GX, Li QQ, Yang BF, Liu Y, Guan LP, Wu MM, et al. Acupuncture for Vascular Dementia: A Pragmatic Randomized Clinical Trial. ScientificWorldJournal. 2015;2015:161439.
  43. Shi GX, Liu CZ, Guan W, Wang ZK, Wang L, Xiao C, et al. Effects of acupuncture on Chinese medicine syndromes of vascular dementia. Chin J Integr Med. 2014;20(9):661-6. https://doi.org/10.1007/s11655-013-1323-4
  44. Lee GE, Cheong MJ, Lee SI, Kim NK, Kim JW. Kang HW. Retrospective Analysis of Patients Suffering from Dementia or Mild Cognitive Impairment Treated by Collaboration between Western and Korean Medicine. J of Oriental Neuropsychiatry. 2018;29(2):111-9. https://doi.org/10.7231/JON.2018.29.2.111
  45. Harandi AA, Abolfazli R, Hatemian A, Ghragozlee K, Ghaffar-Pour M, Karimi M, et al. Safety and Efficacy of MLC601 in Iranian Patients after Stroke: A Double-Blind, Placebo-Controlled Clinical Trial. Stroke Res Treat. 2011;2011:721613.
  46. Heurteaux C, Gandin C, Borsotto M, Widmann C, Brau F, Lhuillier M, et al. Neuroprotective and neuroproliferative activities of NeuroAid (MLC601, MLC901), a Chinese medicine, in vitro and in vivo. Neuropharmacology. 2010;58(7):987-1001. https://doi.org/10.1016/j.neuropharm.2010.01.001
  47. Gandin C, Widmann C, Lazdunski M, Heurteaux C. MLC901 Favors Angiogenesis and Associated Recovery after Ischemic Stroke in Mice. Cerebrovasc Dis. 2016;42(1-2):139-54. https://doi.org/10.1159/000444810
  48. Venketasubramanian N, Lee CF, Young SH, Tay SS, Umapathi T, Lao AY, et al.; CHIMES-E Study Investigators. Prognostic Factors and Pattern of Long-Term Recovery with MLC601 ($NeuroAiD^{TM}$) in the Chinese Medicine NeuroAiD Efficacy on Stroke Recovery-Extension Study. Cerebrovasc Dis. 2017;43(1-2):36-42. https://doi.org/10.1159/000452285
  49. Tian J, Shi J, Wei M, Qin R, Ni J, Zhang X, et al. The efficacy and safety of Fufangdanshen tablets (Radix Salviae miltiorrhizae formula tablets) for mild to moderate vascular dementia: a study protocol for a randomized controlled trial. Trials. 2016;17(1):281. https://doi.org/10.1186/s13063-016-1410-5
  50. Protective effects of Compound Danshen Tablets on rat with vascular dementia caused by ischemia and reperfusion in middle cerebral artery. Pharmacol Clin Chin Materia Medica. 2015;01:177-80.
  51. Zhang XY, Qin X, Zhang YF, Lin J, Wang DQ, Qin RA. et al. Network pharmacology study on major active compounds of Fufang Danshen formula. Zhongguo Zhong Yao Za Zhi. 2011;36(21):2911-5.
  52. China Association of Chinese Medicine, Chinese Medicine Standardization Branch of Chinese Medicine Standard Resaerch Center, Chinese Medicine Standard Research Center of China Academy of Chinese Medical Sciences. Guideline of Clinical Practice in Chinese Medicine-Vascuar Dementia(ZYYXH/T135- 2008). Bejing: China Press of Traditional Chinese Medicine. 2015.
  53. Shi J, Ni J, Lu T, Zhang X, Wei M, Li T, et al. Adding Chinese herbal medicine to conventional therapy brings cognitive benefits to patients with Alzheimer's disease: a retrospective analysis. BMC Complement Altern Med. 2017 Dec;17(1):533. https://doi.org/10.1186/s12906-017-2040-5
  54. Keiko H, Hiromi R, Hisahiro Y, Atsuchi M, Takahiro S, Toshio O. Effect of kihito extract granules on cognitive function in patients with Alzheimer's s-type dementia. Geriatr Gerontol Int. 2007;7(3):245-51. https://doi.org/10.1111/j.1447-0594.2007.00407.x
  55. Lee GE, Yang HD, Jeon WK, Kang Hw. A Study on the system of collaborative practice between korean traditional medicine and western medicine for dementia based on a case study. J of Oriental Neuropsychiatry. 2013:24(3):211-228. https://doi.org/10.7231/jon.2013.24.3.211
  56. Iadecola C. The pathobiology of vascular dementia. Neuron. 2013 Nov 20;80(4):844-66. https://doi.org/10.1016/j.neuron.2013.10.008
  57. Erkinjuntti T, Gauthier S. The concept of vascular cognitive impairment. Front Neurol Neurosci. 2009;24:79-85. https://doi.org/10.1159/000197886
  58. Lorius N, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Viswanathan A, et al.; Alzheimer's Disease Neuroimaging Initiative. Vascular disease and risk factors are associated with cognitive decline in the alzheimer disease spectrum. Alzheimer Dis Assoc Disord. 2015;29(1):18-25. https://doi.org/10.1097/WAD.0000000000000043
  59. Dugger BN, Malek-Ahmadi M, Monsell SE, Kukull WA, Woodruff BK, Reiman EM, et al. A Cross-Sectional Analysis of Late-Life Cardiovascular Factors and Their Relation to Clinically Defined Neurodegenerative Diseases. Alzheimer Dis Assoc Disord. 2016;30(3):223-9. https://doi.org/10.1097/WAD.0000000000000138
  60. Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet. 2002 Apr 13;359(9314):1283-90. https://doi.org/10.1016/S0140-6736(02)08267-3
  61. Ballard C, Sauter M, Scheltens P, He Y, Barkhof F, van Straaten EC, et al. Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study. Curr Med Res Opin. 2008;24(9):2561-74. https://doi.org/10.1185/03007990802328142
  62. Zeng L, Zou Y, Kong L, Wang N, Wang Q, Wang L, et al. Can Chinese Herbal Medicine Adjunctive Therapy Improve Outcomes of Senile Vascular Dementia? Systematic Review with Meta-analysis of Clinical Trials. Phytother Res. 2015;29(12):1843-57. https://doi.org/10.1002/ptr.5481

Cited by

  1. 한의학과 서양의학의 협진 프로세스를 통한 협진 현황 보고 vol.29, pp.3, 2019, https://doi.org/10.18325/jkmr.2019.29.3.129
  2. 치매(痴呆)에 대한 임상 한의학 연구 경향 분석 : 지난 10년간의 국내 논문을 중심으로 vol.24, pp.1, 2020, https://doi.org/10.25153/spkom.2020.24.1.004